abstract |
Disclosed herein are methods for treating solid tumors (eg, pancreatic cancer (PDA), colorectal cancer (CRC), hepatocellular carcinoma (HCC), or bile duct cancer, etc.), including but not limited to metastatic tumors, using anti- Galectin-9 antibody. |